$ Value
$0
Shares
201,804
Price
$0
Filed
Mar 3
Insider
Name
Hider Andrew P.
Title
President and CEO
CIK
0001940945
Roles
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
572,239
Footnotes
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. | Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan. | The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Filing Info
Hider Andrew P.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | BAX | A | $0 |
| 2026-02-27 | BAX | A | $0 |
| 2025-09-02 | BAX | A | $0 |
| 2025-09-02 | BAX | A | $0 |
| 2025-09-02 | BAX | A | $0 |
| 2025-05-06 | TNC | A | $0 |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-06 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |